×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
PR Newswire
PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the...
1 day ago
Here's Why You Should Hold on to Nevro (NVRO) Stock for Now
Yahoo News Singapore
Nevro Corp. NVRO is well-poised for growth in the coming quarters, backed by its solid foothold in the Spinal Cord Stimulation ("SCS")...
3 days ago
Nevro's (NVRO) Q1 Earnings and Sales Beat Estimates, Margins Up
MSN
Nevro Corp. NVRO reported a loss per share of 70 cents in the first quarter of 2024 compared with the year-ago quarter's loss of 98 cents.
2 days ago
Watkins Advises Nevro Corp on Acquisition of Vyrsa Technologies Secured Financing Braidwell
Latham & Watkins LLP
Latham & Watkins Advises Nevro Corp. on Acquisition of Vyrsa™ Technologies and Secured Financing Deal from Braidwell ... A cross-border team...
5 months ago
Nevro promotes new chief operating officer from within
MassDevice
Nevro (NYSE:NVRO) announced that it appointed Christofer Christoforou as its new chief operating officer, effective May 15.
2 weeks ago
Nevro Corp. (NYSE:NVRO) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Simply Wall Street
To the annoyance of some shareholders, Nevro Corp. ( NYSE:NVRO ) shares are down a considerable 27% in the last month...
3 weeks ago
Nevro to Present at BofA Securities 2024 Healthcare Conference
WATE 6 On Your Side
REDWOOD CITY, Calif., May 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive...
2 weeks ago
Nevro Reports First-Quarter 2024 Financial Results
PR Newswire
REDWOOD CITY, Calif., May 7, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive,...
3 weeks ago
Citigroup Downgrades Nevro (NVRO)
MSN
Fintel reports that on May 22, 2024, Citigroup downgraded their outlook for Nevro (NYSE:NVRO) from Neutral to Sell.
4 days ago
Nevro Announces Acquisition of Vyrsa™ Technologies
PR Newswire
Nevro CEO Kevin Thornal commented, "The acquisition of Vyrsa leverages Nevro's ability to drive long-term shareholder value by accelerating our...
5 months ago